Arvinas Inc., of New Haven, Conn., appointed Wendy Dixon to its board.
Avrobio Inc., of Cambridge, Mass., appointed Kim Raineri chief manufacturing and technology officer.
Cara Therapeutics Inc., of Stamford, Conn., appointed Susan Shiff to its board.
Evaxion Biotech A/S, of Copenhagen, appointed Kim Bjoernstrup chair of its board. It also named Helen M. Boudreau to the board and chair of its audit committee.
Leo Pharma A/S, of Ballerup, Denmark, appointed Monica Shaw executive vice president, Region Europe+, effective July 1. It also named Nathalie Joannes executive vice president, legal and compliance and general counsel, effective Sept. 1.
Mereo Biopharma Group plc, of London, appointed John Lewicki chief scientific officer and Ann Kapoun senior vice president of translational research and development.